WallStreetZenWallStreetZen

NASDAQ: SPRO
Spero Therapeutics Inc Stock

Open Broker Account
$1.97-0.08 (-3.9%)
Updated Sep 29, 2022
SPRO Price
$1.97
Fair Value Price
$3.35
Market Cap
$69.08M
52 Week Low
$0.68
52 Week High
$18.84
P/E
-0.56x
P/B
1.92x
P/S
2.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.87M
Earnings
-$113.27M
Gross Margin
100%
Operating Margin
-1,101.59%
Profit Margin
-1,147.6%
Debt to Equity
0.77
Operating Cash Flow
-$84M
Beta
0.91
Next Earnings
Nov 8, 2022
Ex-Dividend
N/A
Next Dividend
N/A

SPRO Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SPRO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SPRO ($1.97) is undervalued by 41.14% relative to our estimate of its Fair Value price of $3.35 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SPRO ($1.97) is significantly undervalued by 41.14% relative to our estimate of its Fair Value price of $3.35 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SPRO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SPRO due diligence checks available for Premium users.

Be the first to know about important SPRO news, forecast changes, insider trades & much more!

SPRO News

Valuation

SPRO fair value

Fair Value of SPRO stock based on Discounted Cash Flow (DCF)
Price
$1.97
Fair Value
$3.35
Undervalued by
41.14%
SPRO ($1.97) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SPRO ($1.97) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SPRO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SPRO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.56x
Industry
14.01x
Market
27.81x

SPRO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.92x
Industry
4.39x
SPRO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SPRO's financial health

Profit margin

Revenue
$2.0M
Net Income
-$28.7M
Profit Margin
-1,439.1%
SPRO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SPRO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$63.6M
Liabilities
$27.7M
Debt to equity
0.77
SPRO's short-term assets ($51.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SPRO's short-term assets ($51.95M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SPRO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SPRO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$23.0M
Investing
$50.0M
Financing
-$53.7M
SPRO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SPRO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
SPRO$69.08M-3.90%-0.56x1.92x
INKT$69.58M-2.83%-1.79x5.08x
SYBX$68.54M+2.74%-1.07x0.58x
CNTB$70.06M+0.83%-0.70x0.34x
CRIS$67.76M-1.60%-1.19x1.09x

Spero Therapeutics Stock FAQ

What is Spero Therapeutics's quote symbol?

NASDAQ: SPRO) Spero Therapeutics trades on the NASDAQ under the ticker symbol SPRO. Spero Therapeutics stock quotes can also be displayed as NASDAQ: SPRO.

If you're new to stock investing, here's how to buy Spero Therapeutics stock.

What is the 52 week high and low for Spero Therapeutics (NASDAQ: SPRO)?

(NASDAQ: SPRO) Spero Therapeutics's 52-week high was $18.84, and its 52-week low was $0.68. It is currently -89.54% from its 52-week high and 189.71% from its 52-week low.

How much is Spero Therapeutics stock worth today?

(NASDAQ: SPRO) Spero Therapeutics currently has 35,067,477 outstanding shares. With Spero Therapeutics stock trading at $1.97 per share, the total value of Spero Therapeutics stock (market capitalization) is $69.08M.

Spero Therapeutics stock was originally listed at a price of $11.50 in Nov 2, 2017. If you had invested in Spero Therapeutics stock at $11.50, your return over the last 4 years would have been -82.87%, for an annualized return of -35.67% (not including any dividends or dividend reinvestments).

How much is Spero Therapeutics's stock price per share?

(NASDAQ: SPRO) Spero Therapeutics stock price per share is $1.97 today (as of Sep 29, 2022).

What is Spero Therapeutics's Market Cap?

(NASDAQ: SPRO) Spero Therapeutics's market cap is $69.08M, as of Oct 1, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Spero Therapeutics's market cap is calculated by multiplying SPRO's current stock price of $1.97 by SPRO's total outstanding shares of 35,067,477.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.